You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Restoring diabetic tactile sense using mechanical noise
SBC: AFFERENT CORPORATION Topic: N/ADESCRIPTION (provided by applicant): More than 10 million individuals in the U.S. are thought to suffer from diabetic neuropathies. Many serious medical problems stem from this condition, including degradation of the mechanical senses of touch and propri
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Implantable Noise-based Sensory Enhancement Devices
SBC: AFFERENT CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Stroke survivors constitute one of the largest groups of patients receiving rehabilitation services in the United States. The inability of most stroke survivors to regain full sensorimotor function significantly impacts quality of life while generating tremendous ongoing health care costs and losses to productivity. Recent scientific and clinical findings have ...
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Implantable Noise-based Sensory Enhancement Devices
SBC: AFFERENT CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Stroke survivors constitute one of the largest groups of patients receiving rehabilitation services in the United States. The inability of most stroke survivors to regain full sensorimotor function significantly imp
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Resolving Biological Entity References (Text/Databases)
SBC: ALIAS-I Topic: N/ADESCRIPTION (provided by applicant): In the broadest terms, the goal of the proposed work is to make it easier for researchers to apply robust, scalable, entity-centered, heterogeneous data access to the biomedical literature. 'Entity centered' means th
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Low-temperature Electrocatalytic Oxidation of VOCs
SBC: AMSEN TECHNOLOGIES LLC Topic: N/ADESCRIPTION (provided by applicant): In this program AMSEN Technologies aims to develop a novel electrocatalytic air filter for low-temperature oxidative destruction of VOCs. The proposed idea is an innovative combination of electrochemically enhanced ads
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Refanalin for Liver Transplantation
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Orthotopic liver transplantation is the most effective treatment for patients with end-stage liver disease. Ischemia-reperfusion injury associated with the retrieval, storage and transplantation of livers is a major
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Hepatic Growth Factor Mimetic for Liver Fibrosis
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Hepatic fibrosis, a disease affecting tens of millions of patients worldwide, is the liver scarring response to chronic injury from viral hepatitis B or C, excessive alcohol use, iron overload or extrahepatic obstr
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Kidney Preservation for Transplantation
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Renal transplantation is the most effective and cost efficient treatment for patients with established renal disease. However ischemia-reperfusion injury associated with the retrieval, storage and transplantation of ki
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic Potential of Refanalin in Pulmonary Fibrosis
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Idiopathic pulmonary fibrosis (IPF) is a devastating disease with less than a 50% five-year survival. While steroids and other immunosuppressive agents serve as the standard treatment for IPF, these agents have pro
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Protection from Stroke by SF/HGF-like Small Molecule
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Atherosclerosis of the cerebral vasculature can produce occlusion and cerebral infarction. Although the tissue in the ischemia core dies within minutes, the surrounding tissue, termed the ischemic penumbra, sustain
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health